雜志介紹
Therapeutic Advances In Cardiovascular Disease雜志介紹
《Therapeutic Advances In Cardiovascular Disease》是一本以English為主的開放獲取國際優秀期刊,中文名稱心血管疾病治療進展,本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業的最新進展,探討行業發展的思路和方法,以促進學術信息交流,提高行業發展。該刊已被國際權威數據庫SCIE收錄,為該領域相關學科的發展起到了良好的推動作用,也得到了本專業人員的廣泛認可。該刊最新影響因子為2.6,最新CiteScore 指數為3.5。
英文介紹
Therapeutic Advances In Cardiovascular Disease雜志英文介紹
Therapeutic Advances in Cardiovascular Disease is an international peer-reviewed journal focused on the treatment of cardiovascular diseases. This journal is dedicated to publishing innovative research in the treatment of heart and circulatory system diseases, including original research articles, reviews, and academic reviews. It focuses on clinical and pharmacological aspects and is aimed at clinical doctors and researchers in cardiology, circulatory system diseases, and related disciplines worldwide, with the aim of rapidly disseminating the latest research and perspectives in this field.
The magazine editorial team is composed of experts from around the world who conduct rigorous peer review of manuscripts to ensure that the published content has high quality and academic value. The magazine not only focuses on basic research, but also emphasizes the exploration of clinical practice and treatment strategies, providing readers with in-depth academic discussions and practical guidance. It is an academic journal dedicated to the research of cardiovascular disease treatment, providing a platform for researchers worldwide to showcase and exchange research results, especially in understanding the treatment strategies and clinical applications of cardiovascular disease, which has important academic value and practical significance.
JCR分區(2023-2024年最新版)
Therapeutic Advances In Cardiovascular Disease雜志 JCR分區信息
按JIF指標學科分區 |
學科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區:Q2
排名:84 / 220
|
按JCI指標學科分區 |
學科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區:Q3
排名:128 / 220
|
JCR分區:JCR分區來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數據的統計信息的期刊評價資源。每年發布的JCR分區,設置了254個具體學科。JCR分區根據每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區,分別為Q1、Q2、Q3和Q4,各占25%。JCR分區中期刊的數量是均勻分為四個部分的。
CiteScore 評價數據(2024年最新版)
Therapeutic Advances In Cardiovascular Disease雜志CiteScore 評價數據
- CiteScore 值:3.5
- SJR:0.553
- SNIP:0.779
學科類別 |
分區 |
排名 |
百分位 |
大類:Medicine
小類:Cardiology and Cardiovascular Medicine
|
Q2
|
177 / 387
|
|
大類:Medicine
小類:Pharmacology (medical)
|
Q3
|
148 / 272
|
|
投稿經驗
Therapeutic Advances In Cardiovascular Disease雜志投稿經驗
該雜志是一本國際優秀雜志,在國際上有較高的學術影響力,行業關注度很高,已被國際權威數據庫SCIE收錄,該雜志在綜合專業領域專業度認可很高,對稿件內容的創新性和學術性要求很高,作為一本國際優秀雜志,一般投稿過審時間都較長,投稿過審時間平均 9 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。